We and others have recently found that GRB7 and its variant, GRB7v, are frequently upregulated in ovarian cancers and are able to enhance cell proliferation, migration/invasion through activating ERK signaling pathway [12], [36], [37]. This evidence concerns the gene GRB7 and ovarian carcinoma.